As shown by us and others, south Asians and blacks and likely other ethnic groups are more likely to develop type 2 diabetes at lower weight gains than whites across all ages, so that even small population-wide gains in obesity in many countries will lead to large rises in diabetes, Sattar said, adding there was even some trial evidence that drugs that mimic GLP-1 may lower risks of heart disease by almost twice as much in Asian people than in white people
On Wednesday 4/1/26, the Food and Drug Administration (FDA) approved Eli Lillys new oral weight-loss pill, orforglipron , a GLP-1 drug that works like the widely used injectable medications
USA: Elsevier
Disclaimer: The information provided in this blog is for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment
While some clinicians have observed that patients with a pre-existing history of migraine or tension-type headaches might be more susceptible to experiencing headaches when initiating semaglutide therapy, this association has not been systematically studied in large-scale trials